Philips Introduces Newest Iteration of DoseWise Portal
|
By Daniel Beris Posted on 01 Dec 2016 |

Image: The DoseWise Portal 2.2 (Photo courtesy of Philips Healthcare).
Next-generation radiation dose software offers enhanced customization features to further mitigate radiation risk for patients and staff.
The Royal Philips (Amsterdam, The Netherlands) DoseWise Portal 2.2 includes enhanced connectivity and informatics capabilities to address key challenges faced by radiology departments, such as managing dose exposure to ensure patient and staff wellbeing and improving integrated access to patient information in order to deliver data-driven decision support. Philips DoseWise Portal 2.2 now integrates with key Philips health IT systems, as well as third-party radiology dictation software, which include:
IntelliSpace PACS – Users may view the patient's exam radiation exposure directly from the picture archiving and communication system (PACS) image, or by retrieving the patient's total radiation exposure exam history from the modality worklist.
IntelliBridge Enterprise – Allows users to query/retrieve crucial updated patient demographics from the hospital's electronic medical record (EMR), such as body mass index (BMI) weight and age, for use with the DoseWise Portal. And it can also be used in conjunction with radiology dictation software to enable patient radiation exposure to be populated into dictation reports, saving time and helping to reduce transcription errors.
In addition to the expanded integrations, the platform also includes expanded connectivity to Philips DoseAware products that combine patient and staff dose information into a single display for deep analytics of radiation exposure. A customized, user-friendly analytics package with an intuitive user interface and enhanced charting and graphing functionality simplifies reporting needs, and includes a customizable dashboard and popular reporting formats.
“This next generation of DoseWise Portal provides clinicians with a full picture of the patient's exposure history within that institution, for enhanced decision support to ensure proper dose optimization and justification for exam ordering is accomplished right the first time,” said Dominic Siewko, clinical marketing leader and former radiation safety officer at Philips. “The new features in DoseWise Portal promote a culture of safety in the radiology department while allowing clinicians to tap into deep analytics and actionable insights from radiation exposure data.”
Collectively, these new features enable clinicians to access more patient information, helping them to more easily interpret patient radiation dose per exam across modalities and analyze overall cumulative exposure.
Related Links:
Royal Philips
The Royal Philips (Amsterdam, The Netherlands) DoseWise Portal 2.2 includes enhanced connectivity and informatics capabilities to address key challenges faced by radiology departments, such as managing dose exposure to ensure patient and staff wellbeing and improving integrated access to patient information in order to deliver data-driven decision support. Philips DoseWise Portal 2.2 now integrates with key Philips health IT systems, as well as third-party radiology dictation software, which include:
IntelliSpace PACS – Users may view the patient's exam radiation exposure directly from the picture archiving and communication system (PACS) image, or by retrieving the patient's total radiation exposure exam history from the modality worklist.
IntelliBridge Enterprise – Allows users to query/retrieve crucial updated patient demographics from the hospital's electronic medical record (EMR), such as body mass index (BMI) weight and age, for use with the DoseWise Portal. And it can also be used in conjunction with radiology dictation software to enable patient radiation exposure to be populated into dictation reports, saving time and helping to reduce transcription errors.
In addition to the expanded integrations, the platform also includes expanded connectivity to Philips DoseAware products that combine patient and staff dose information into a single display for deep analytics of radiation exposure. A customized, user-friendly analytics package with an intuitive user interface and enhanced charting and graphing functionality simplifies reporting needs, and includes a customizable dashboard and popular reporting formats.
“This next generation of DoseWise Portal provides clinicians with a full picture of the patient's exposure history within that institution, for enhanced decision support to ensure proper dose optimization and justification for exam ordering is accomplished right the first time,” said Dominic Siewko, clinical marketing leader and former radiation safety officer at Philips. “The new features in DoseWise Portal promote a culture of safety in the radiology department while allowing clinicians to tap into deep analytics and actionable insights from radiation exposure data.”
Collectively, these new features enable clinicians to access more patient information, helping them to more easily interpret patient radiation dose per exam across modalities and analyze overall cumulative exposure.
Related Links:
Royal Philips
Latest Radiography News
- AI Detection Tool Improves Identification of Lobular Breast Cancer
- New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
- AI Boosts Breast Cancer Detection and Cuts Screening Workload
- AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
- Routine Mammograms Could Predict Future Cardiovascular Disease in Women
- AI Detects Early Signs of Aging from Chest X-Rays
- X-Ray Breakthrough Captures Three Image-Contrast Types in Single Shot
- AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
- AI Algorithm Uses Mammograms to Accurately Predict Cardiovascular Risk in Women
- AI Hybrid Strategy Improves Mammogram Interpretation
- AI Technology Predicts Personalized Five-Year Risk of Developing Breast Cancer
- RSNA AI Challenge Models Can Independently Interpret Mammograms
- New Technique Combines X-Ray Imaging and Radar for Safer Cancer Diagnosis
- New AI Tool Helps Doctors Read Chest X‑Rays Better
- Wearable X-Ray Imaging Detecting Fabric to Provide On-The-Go Diagnostic Scanning
- AI Helps Radiologists Spot More Lesions in Mammograms
Channels
MRI
view channel
MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
Cell therapies for myocardial injury face a persistent hurdle: clinicians cannot easily monitor whether transplanted cells survive and where they persist in the heart. This limits optimization of dosing,... Read more
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreUltrasound
view channel
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read more
New Consensus Standardizes Ultrasound-Based Fatty Liver Assessment
Metabolic dysfunction-associated steatotic liver disease (MASLD) is rising along with obesity and diabetes, making accurate, scalable measurement of hepatic fat a clinical priority. Biopsy is invasive... Read moreNuclear Medicine
view channel
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
Routine Cardiac CT Enhanced to Predict Heart Failure Risk
Heart failure, a progressive inability of the heart to pump blood effectively, often develops silently before symptoms appear. Clinicians need reliable ways to detect myocardial injury early and stratify... Read more
New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
Breast evaluation often requires correlating findings from mammography, digital breast tomosynthesis, MRI, ultrasound, and newer volumetric techniques. Switching between separate viewers to track changes... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







